Ongoing clinical trials and approved products targeting Sentinel lymph node, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.
| Lymphoseek[99mTc]tilmanocept | Cardinal Health (US), Norgine (UE) | marketed | US |
| Trial | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
| MagMen-II · Sentinel lymph node tracersNCT07552597 · Melanoma | Phase 3 | Not yet recruiting | Vastra Gotaland Region | 0 |
| Sentinel lymph node tracers2024-514233-37-00 · Solid tumors (multiple indications) | Phase 3 | Recruiting | Universitair Medisch Centrum Utrecht | 1 |
| MagSnow2 · Sentinel lymph node tracersNCT06169072 · Breast | Phase 2 | Recruiting | Vastra Gotaland Region | 1 |
| Sentinel lymph node tracersNCT07159074 · Other | Phase 2 | Recruiting | Duke University | 1 |
| INFINITE · Sentinel lymph node tracersNCT07146295 · Breast | No phase | Recruiting | Isabelle Henskens | 1 |
| INFLUENCE II · Sentinel lymph node tracersNCT07311278 · Breast | No phase | Active, not recruiting | St. Antonius Hospital | 2 |
| INFLUENCE II · Sentinel lymph node tracersNCT07441733 · Breast | No phase | Recruiting | Casa di Cura Dott. Pederzoli | 1 |
| Melisa-II · Sentinel lymph node tracersNCT05937620 · Gynecological | No phase | Recruiting | Fundacion Clinic per a la Recerca Biomédica | 1 |
Sentinel lymph node. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/sentinel-lymph-node/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.